Xencor (XNCR) Retained Earnings (2013 - 2026)
Xencor's (XNCR) quarterly Retained Earnings came in at $27000.0 in Q1 2026, down 100.0% year-on-year from $1.4 billion in Q1 2025, and up 100.0% on a QoQ basis from -$796.0 million in Q4 2025.
Xencor (XNCR) Retained Earnings (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Retained Earnings data on file, last reported at $27000.0 in Q1 2026.
- On a quarterly basis, Retained Earnings fell 100.0% year-over-year to $27000.0 in Q1 2026; TTM through Mar 2026 was $27000.0, a 100.0% decrease from a year earlier, with the FY2025 full-year figure at -$796.0 million, down 157.61% from the prior year.
- Retained Earnings for Q1 2026 stood at $27000.0, up from -$796.0 million in the prior quarter.
- Over the last five years, Retained Earnings for XNCR reached as high as $1.4 billion in Q1 2025 and fell as low as -$796.0 million in Q4 2025.
- Historically, Retained Earnings has averaged $149.6 million across 5 years, with a median of -$652000.0 in 2024.
- On a YoY basis, Retained Earnings climbed as much as 903516.23% in 2025 and fell as far as 120034.82% in 2025.
- Year by year, Retained Earnings stood at -$338.3 million in 2022, then surged by 100.38% to $1.3 million in 2023, then jumped by 106918.36% to $1.4 billion in 2024, then plunged by 157.61% to -$796.0 million in 2025, then jumped by 100.0% to $27000.0 in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were $27000.0 in Q1 2026, -$796.0 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | 27,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,000.00 |
| Dec 31, 2025 | -795.96 Mn |
| Sep 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | -783.28 Mn |
| Mar 31, 2025 | 1.39 Bn |
| Dec 31, 2024 | 1.38 Bn |
| Sep 30, 2024 | 1.36 Bn |
| Jun 30, 2024 | -652,000.00 |
| Mar 31, 2024 | -154,000.00 |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | -709,000.00 |
| Jun 30, 2023 | -421.00 Mn |
| Mar 31, 2023 | 1.09 Bn |
| Dec 31, 2022 | -338.29 Mn |
| Sep 30, 2022 | -326.24 Mn |
| Jun 30, 2022 | -8.94 Mn |
| Mar 31, 2022 | -7.12 Mn |
| Dec 31, 2021 | -283.10 Mn |
| Sep 30, 2021 | -356.17 Mn |
| Jun 30, 2021 | 962.34 Mn |